Case reportPhotodynamic therapy in the treatment of oral lesions caused by paracoccidiomycosis
Introduction
Paracoccidioidomycosis (PCM) is an endemic disease caused by the dimorphic fungus Paracocdioides brasiliensis and Paracoccidioides lutzii. The disease is more prevalent in men, with a mean age of 51.3 years. In Brazil, the south and southeast are the regions with the highest incidence, and mortality in endemic areas is around 20% [1]. The disease sets in when the spores are inhaled, mainly affecting the lungs. Other regions and organs are affected by lympho-hematological dissemination, including the oral mucosa [2].
PCM can be classified as acute (or subacute or juvenile) and chronic (unifocal or multifocal). In the first one, the manifestation occurs in children and young people up to 30 years of age, of both sexes. The chronic form affects adults over 30 years of age, with a 15:1 male-to-female ratio [1–4]. In both forms, the treatment must be done individually, using antifungal agents and systemic antibiotics, taking into account the morbidities, nutritional status and administration of medications for continuous use [4].
Manifestations in the oral mucosa are usually the first clinical signs of the disease, aiding in the clinical diagnosis, which is often delayed. Due to the ulcerated aspect, lesions associated with PCM have squamous cell carcinoma as a differential diagnosis [2,3]. The diagnosis is confirmed through incisional biopsies, showing pseudoepitheliomatous hyperplasia, epithelial discontinuity, chronic inflammatory infiltrate with multinucleated giant cells. Special staining techniques such as Periodic Acid Schiff (PAS) and Grocott-Gomori methenamine silver can identify Paracocdioides brasiliensis yeasts in biopsied tissues, which present multiple daughter buds in a so-called aspect of “Mickey Mouse ears” [1].
As it is a systemic fungal disease, local treatments are considered complementary, such as the photodynamic therapy (aPDT). In addition to being potentially effective in healing and analgesia, aPDT acts to eliminate pathogenic microorganisms, with the advantage of not inducing microbial resistance [5,6].
The therapy is based on the application of a photosensitizing agent on the injured tissue followed by low power laser emission on the region. The interaction generates free radicals and oxidation of the plasma membrane of microorganisms, providing antimicrobial and antifungal activity without harming healthy host cells [6].
The aim of this paper is to report a case of PCM with extensive oral manifestations in which aPDT was used as an adjuvant treatment to systemic pharmacological treatment, with positive results, during the patient's hospitalization in the Intensive Care Unit (ICU).
Section snippets
Case report
A 41-year-old caucasian male patient, smoker and chronic drinker for 20 years, presented with ulcerated lesions in the oral cavity for about 6 months, initially in the left buccal mucosa and progressing to the lower lip, with strong intensity painful symptoms. Due to the pain complaint in the oropharynx, the patient reported a reduction in food acceptance, leading to a weight loss of around 40 kg.
He sought medical care in his city in Paraná, Brazil, where a chest X-ray was performed, suggesting
Discussion
The reported case refers to a male individual, in his fifth decade of life, smoker and drinker, residing in an endemic area for PCM, therefore fitting into the risk group for Paracoccidioidomycosis [1,2]. The patient presented classical manifestations of the multifocal chronic form, such as pulmonary involvement, dyspnea, odynophagia, weight loss, lymphadenopathy, manifestations in the oral mucosa and changes in the level of consciousness, requiring treatment in the hospital environment as well
Ethical statement
No ethical statement will be required for this manuscript.
Financial disclose
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
CRediT authorship contribution statement
Danila Silvana de Alexandria Santos: Writing – original draft. Gustavo Souza Galvão: Writing – original draft, Writing – review & editing, Investigation, Methodology. Priscila Fernandes Ribas: Supervision, Methodology, Investigation, Conceptualization. Maria Paula Siqueira de Melo Peres: Conceptualization, Investigation, Methodology, Supervision. Juliana Bertoldi Franco: Writing – original draft, Supervision, Methodology, Investigation, Conceptualization.
Declaration of Competing Interest
All authors declare that they have no conflict of interest.
Acknowledgement
We would like to offer our gratitude to all the colleagues at the Department of Dentistry, Critical Care Medicine and Infectology of Clinical Hospital of Medical School of the University of São Paulo for their helpful discussion and assistance.
References (6)
- et al.
Diagnosis at different stages of paracoccidioidomycosis with oral manifestation: Report of two cases
J. Mycol. Med.
(2020 Dec) - et al.
A multicentre study of oral paracoccidioidomycosis: analysis of 320 cases and literature review
Oral Dis
(2018 Nov) - et al.
Oral paracoccidioidomycosis in a non-endemic region from Brazil: a short case series
J. Clin. Exp. Dent.
(2019 Oct 1)
Cited by (7)
Interaction effects between macromolecules and photosensitizer on the ability of AlPc and InPc-loaded PHB magnetic nanoparticles in photooxidatizing simple biomolecules
2022, International Journal of Biological MacromoleculesCitation Excerpt :The therapeutic properties of light have been used for thousands of years for the treatment of dermatological diseases, such as vitiligo and psoriasis [1,2]. Diseases such as infections and cancer are being treated with Photodynamic Therapy (PDT) [3–6]. PDT is a therapeutic modality that combines the administration of a photosensitizer, a light source to activate it, and oxygen molecules to generate reactive oxygen species (ROS) capable of causing the death of diseased cells [2,7–11].
Phototherapies as an adjuvant treatment for oral paracoccidioidomycosis
2022, Photodiagnosis and Photodynamic TherapyPhotodynamic therapy in the coadjuvant treatment of Sporothrix schenckii complex
2024, Special Care in DentistryAntimicrobial Photodynamic Inactivation of Oral Bacteria
2023, Antimicrobial Photodynamic Therapy: Concepts and Applications